Since the Val66Met genotype is associated with reduced activity-dependent secretion of both pro- and mature BDNF, it is conceivable that carrying the Met allele affords protection against cancer-related fatigue by reducing the proapoptotic effects of proBDNF48. The gene discussed is BDNF; the disease is cancer.